drugset / Trial / NCT00433875
Phase 2 AMG 714 in Rheumatoid Arthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
Twelve week treatment of AMG 714 in RA patients who failed at least one DMARD, followed by a 3 month observational period.
Timeline
- Start
- 2002-12
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ORDESEKIMAB | Monoclonal antibody | — | — |